Announcements Trials
Browse Landscape

Phase

Phase 4 13Phase 2 5Phase 3 3Phase 1 3Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Pain 2Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Colorectal Neoplasms 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Sorafenib 110Temozolomide 109Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Oxycodone × Clear all
NCT03253133 2023-05-03

NIPOX

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1 Completed
19 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02531906 2022-07-25

Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation

Roswell Park Cancer Institute

Phase 1 Completed
60 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Pain, Stomatitis

NCT01482936 2015-08-11

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 1 Completed
44 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡